Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial
Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Tonny Jensen, K Hørslev-Petersen, Kristian Stengaard-Pedersen, Peter Junker, T Ellingsen, P Ahlquist, H Lindegaard, A Linauskas, A Schlemmer, Mette Yde Dam, I Hansen, T Lottenburger, C G Ammitzbøll, A. Jørgensen, Sophine Boysen Krintel, Johnny Raun, Merete Lund Hetland, Ole SlotLars Kjær Nielsen, Henrik Skjødt, Ole Majgaard, Tove Lorenzen, Hans Christian Horn, Marcin Kowalski, Inger Lauge Johansen, Peter Mosborg Pedersen, Natalia Manilo, Henning Bliddal, OPERA Study Group
Dive into the research topics of 'Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial'. Together they form a unique fingerprint.